Cargando…

Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium

BACKGROUND: Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied. We examined the consequences of hypokalemia and borderline hypokalemia correction in patients with hypertension. METHODS: We identified 8976 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Krogager, Maria Lukács, Søgaard, Peter, Torp-Pedersen, Christian, Bøggild, Henrik, Lee, Christina Ji-Young, Bonde, Anders, Thomassen, Jesper Q., Gislason, Gunnar, Pareek, Manan, Kragholm, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446172/
https://www.ncbi.nlm.nih.gov/pubmed/32838735
http://dx.doi.org/10.1186/s12872-020-01654-3
_version_ 1783574116086841344
author Krogager, Maria Lukács
Søgaard, Peter
Torp-Pedersen, Christian
Bøggild, Henrik
Lee, Christina Ji-Young
Bonde, Anders
Thomassen, Jesper Q.
Gislason, Gunnar
Pareek, Manan
Kragholm, Kristian
author_facet Krogager, Maria Lukács
Søgaard, Peter
Torp-Pedersen, Christian
Bøggild, Henrik
Lee, Christina Ji-Young
Bonde, Anders
Thomassen, Jesper Q.
Gislason, Gunnar
Pareek, Manan
Kragholm, Kristian
author_sort Krogager, Maria Lukács
collection PubMed
description BACKGROUND: Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied. We examined the consequences of hypokalemia and borderline hypokalemia correction in patients with hypertension. METHODS: We identified 8976 patients with hypertension and plasma potassium concentrations ≤3.7 mmol/L within 100 days from combination antihypertensive therapy initiation. The first measurement between 6 and 100 days after the episode with potassium ≤3.7 mmol/L was retained. We investigated all-cause and cardiovascular mortality within 60-days from the second potassium measurement using Cox regression. Mortality was examined for seven predefined potassium intervals derived from the second measurement: 1.5–2.9 mmol/L (n = 271), 3.0–3.4 mmol/L (n = 1341), 3.5–3.7 (n = 1982) mmol/L, 3.8–4.0 mmol/L (n = 2398, reference), 4.1–4.6 mmol/L (n = 2498), 4.7–5.0 mmol/L (n = 352) and 5.1–7.1 mmol/L (n = 134). RESULTS: Multivariable analysis showed that potassium concentrations 1.5–2.9 mmol/L, 3.0–3.4 mmol/L, 4.7–5.0 mmol/L and 5.1–7.1 mmol/L were associated with increased all-cause mortality (HR 2.39, 95% CI 1.66–3.43; HR 1.36, 95% CI 1.04–1.78; HR 2.36, 95% CI 1.68–3.30 and HR 2.62, 95% CI 1.73–3.98, respectively). Potassium levels <3.0 and > 4.6 mmol/L were associated with increased cardiovascular mortality. The adjusted standardized 60-day mortality risks in the seven strata were: 11.7% (95% CI 8.3–15.0%), 7.1% (95% CI 5.8–8.5%), 6.4% (95% CI 5.3–7.5%), 5.4% (4.5–6.3%), 6.3% (5.4–7.2%), 11.6% (95% CI 8.7–14.6%) and 12.6% (95% CI 8.2–16.9%), respectively. CONCLUSIONS: Persistent hypokalemia was frequent and associated with increased all-cause and cardiovascular mortality. Increase in potassium to levels > 4.6 mmol/L in patients with initial hypokalemia or low normal potassium was associated with increased all-cause and cardiovascular mortality.
format Online
Article
Text
id pubmed-7446172
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74461722020-08-26 Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium Krogager, Maria Lukács Søgaard, Peter Torp-Pedersen, Christian Bøggild, Henrik Lee, Christina Ji-Young Bonde, Anders Thomassen, Jesper Q. Gislason, Gunnar Pareek, Manan Kragholm, Kristian BMC Cardiovasc Disord Research Article BACKGROUND: Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied. We examined the consequences of hypokalemia and borderline hypokalemia correction in patients with hypertension. METHODS: We identified 8976 patients with hypertension and plasma potassium concentrations ≤3.7 mmol/L within 100 days from combination antihypertensive therapy initiation. The first measurement between 6 and 100 days after the episode with potassium ≤3.7 mmol/L was retained. We investigated all-cause and cardiovascular mortality within 60-days from the second potassium measurement using Cox regression. Mortality was examined for seven predefined potassium intervals derived from the second measurement: 1.5–2.9 mmol/L (n = 271), 3.0–3.4 mmol/L (n = 1341), 3.5–3.7 (n = 1982) mmol/L, 3.8–4.0 mmol/L (n = 2398, reference), 4.1–4.6 mmol/L (n = 2498), 4.7–5.0 mmol/L (n = 352) and 5.1–7.1 mmol/L (n = 134). RESULTS: Multivariable analysis showed that potassium concentrations 1.5–2.9 mmol/L, 3.0–3.4 mmol/L, 4.7–5.0 mmol/L and 5.1–7.1 mmol/L were associated with increased all-cause mortality (HR 2.39, 95% CI 1.66–3.43; HR 1.36, 95% CI 1.04–1.78; HR 2.36, 95% CI 1.68–3.30 and HR 2.62, 95% CI 1.73–3.98, respectively). Potassium levels <3.0 and > 4.6 mmol/L were associated with increased cardiovascular mortality. The adjusted standardized 60-day mortality risks in the seven strata were: 11.7% (95% CI 8.3–15.0%), 7.1% (95% CI 5.8–8.5%), 6.4% (95% CI 5.3–7.5%), 5.4% (4.5–6.3%), 6.3% (5.4–7.2%), 11.6% (95% CI 8.7–14.6%) and 12.6% (95% CI 8.2–16.9%), respectively. CONCLUSIONS: Persistent hypokalemia was frequent and associated with increased all-cause and cardiovascular mortality. Increase in potassium to levels > 4.6 mmol/L in patients with initial hypokalemia or low normal potassium was associated with increased all-cause and cardiovascular mortality. BioMed Central 2020-08-24 /pmc/articles/PMC7446172/ /pubmed/32838735 http://dx.doi.org/10.1186/s12872-020-01654-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Krogager, Maria Lukács
Søgaard, Peter
Torp-Pedersen, Christian
Bøggild, Henrik
Lee, Christina Ji-Young
Bonde, Anders
Thomassen, Jesper Q.
Gislason, Gunnar
Pareek, Manan
Kragholm, Kristian
Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
title Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
title_full Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
title_fullStr Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
title_full_unstemmed Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
title_short Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
title_sort impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446172/
https://www.ncbi.nlm.nih.gov/pubmed/32838735
http://dx.doi.org/10.1186/s12872-020-01654-3
work_keys_str_mv AT krogagermarialukacs impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT søgaardpeter impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT torppedersenchristian impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT bøggildhenrik impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT leechristinajiyoung impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT bondeanders impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT thomassenjesperq impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT gislasongunnar impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT pareekmanan impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium
AT kragholmkristian impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium